These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 20102209)

  • 1. Synthesis of novel substituted benzimidazo[1,2-a]quinoxalin-6(5H)-ones via an intramolecular Goldberg reaction.
    Meng T; Zhang Y; Li M; Wang X; Shen J
    J Comb Chem; 2010 Mar; 12(2):222-4. PubMed ID: 20102209
    [No Abstract]   [Full Text] [Related]  

  • 2. Design, synthesis and photoinduced DNA cleavage studies of [1,2,4]-triazolo[4,3-a]quinoxalin-4(5H)-ones.
    Sumran G; Aggarwal R; Mittal A; Aggarwal A; Gupta A
    Bioorg Chem; 2019 Jul; 88():102932. PubMed ID: 31028990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of novel quinoxaline derivatives and its cytotoxic activities.
    Tanimori S; Nishimura T; Kirihata M
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4119-21. PubMed ID: 19539470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Convenient synthetic method for 3-(3-substituted indol-2-yl)quinoxalin-2-ones as VEGF inhibitor.
    Aoki K; Koseki J; Takeda S; Aburada M; Miyamoto K
    Chem Pharm Bull (Tokyo); 2007 Jun; 55(6):922-5. PubMed ID: 17541196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-inflammatory/antioxidant activities of some new ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives and of their 4,5-dihydro-(1H)-pyrazole analogues.
    Burguete A; Pontiki E; Hadjipavlou-Litina D; Villar R; Vicente E; Solano B; Ancizu S; Pérez-Silanes S; Aldana I; Monge A
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6439-43. PubMed ID: 17942306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridoquinoxaline N-oxides. 2. Synthesis and antibacterial activity of tricyclic lactams.
    Glazer EA; Presslitz JE
    J Med Chem; 1982 Jul; 25(7):868-70. PubMed ID: 7108904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected imidazoquinoxalinone annulation products in the photoinitiated reaction of substituted-3-methyl-quinoxalin-2-ones with N-phenylglycine.
    De la Fuente JR; Cañete Á; Jullian C; Saitz C; Aliaga C
    Photochem Photobiol; 2013; 89(6):1335-45. PubMed ID: 24033113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient synthesis of mutagenic imidazo[4,5-f] quinoxalin-2-amines via readily accessible 2,1,3-benzoselenadiazoles.
    Grivas S
    Acta Chem Scand B; 1986 May; 40(5):404-6. PubMed ID: 3751433
    [No Abstract]   [Full Text] [Related]  

  • 10. Quinoxaline derivatives. Part II: Synthesis and antimicrobial testing of 1,2,4-triazolo[4,3-a]quinoxalines, 1,2,4-triazino[4,3-a]quinoxalines and 2-pyrazolylquinoxalines.
    el-Hawash SA; Habib NS; Fanaki NH
    Pharmazie; 1999 Nov; 54(11):808-13. PubMed ID: 10603606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Phenyl-substituted imidazo[1,5-alpha]quinoxalin-4-ones and imidazo[1,5-alpha]quinoxaline ureas that have high affinity at the GABAA/benzodiazepine receptor complex.
    Jacobsen EJ; Stelzer LS; Belonga KL; Carter DB; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD
    J Med Chem; 1996 Sep; 39(19):3820-36. PubMed ID: 8809170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution-phase parallel synthesis of a 1,2,7-trialkyl-1H-imidazo[4,5-g]quinoxalin-6-ol library scaffold.
    Zhang J; Zhang L; Zhang S; Wang Y; Liu G
    J Comb Chem; 2005; 7(5):657-64. PubMed ID: 16153059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cu(II)-mediated synthesis of a new fluorescent pyrido[1,2-a]quinoxalin-11-ium derivative.
    Koner RR; Ray M
    Inorg Chem; 2008 Oct; 47(20):9122-4. PubMed ID: 18795776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new strategy for the construction of the imidazo[1,5-a]quinoxalin-4-one ring system and its application to the efficient synthesis of BMS-238497, a novel and potent Lck inhibitor.
    Chen BC; Zhao R; Bednarz MS; Wang B; Sundeen JE; Barrish JC
    J Org Chem; 2004 Feb; 69(3):977-9. PubMed ID: 14750833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimicrobial testing of thiazolinyl-, thiazolidinonyl-quinoxalines and 1,2,4-triazolo[4,3-a]quinoxalines.
    Habib NS; el-Hawash SA
    Pharmazie; 1997 Aug; 52(8):594-8. PubMed ID: 9292917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The construction of benzimidazo[2,1-
    Kang QQ; Zhang WK; Ge GP; Zheng H; Wei WT
    Org Biomol Chem; 2021 Oct; 19(41):8874-8885. PubMed ID: 34610071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants.
    Wagle S; Adhikari AV; Kumari NS
    Eur J Med Chem; 2009 Mar; 44(3):1135-43. PubMed ID: 18672315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel isocyanide-based three-component synthesis of 3,4-dihydroquinoxalin-2-amine derivatives.
    Shaabani A; Maleki A; Mofakham H; Khavasi HR
    J Comb Chem; 2008; 10(2):323-6. PubMed ID: 18237143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel synthetic approach to 6,7-dihydro-5H-imidazo[1,5-a]-pyrazin-8-ones.
    Gopalsamy A; Shi M
    Org Lett; 2003 Oct; 5(21):3907-9. PubMed ID: 14535740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
    El-Hawash SA; Habib NS; Kassem MA
    Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.